about
Vitamin D receptor gene polymorphisms in multiple sclerosis patients in northwest Greece.High-dose intravenous immunoglobulin in the treatment of adult patients with bullous pemphigoid.Systematic review of the association between Alzheimer's disease and chronic glaucoma.The effect of menarche age, parity and lactation on bone mineral density in premenopausal ambulatory multiple sclerosis patients.Increased sensitivity to N-methyl-D-aspartate receptor-induced excitotoxicity in cerebellar granule cells from interleukin-1 receptor type I-deficient mice.MRI deterioration in herpes simplex encephalitis despite clinical recovery.The effectiveness of hydrokinesiotherapy on postural balance of hemiplegic patients after stroke: a systematic review and meta-analysis.Neurological manifestations of connective tissue diseases mimicking multiple sclerosis.Vertebral artery hypoplasia: a predisposing factor for posterior circulation stroke?Thrombosis and recanalization of straight sinus.Perimetric and peri-papillary nerve fibre layer thickness findings in multiple sclerosis.Risk factors for cognitive dysfunction in CKD and hypertensive subjects.Polyautoimmunity in a Greek cohort of multiple sclerosis.Body composition in ambulatory patients with multiple sclerosis.Bone mineral density in ambulatory patients with multiple sclerosis.Multiple sclerosis associated with systemic sclerosis.HLA associations with multiple sclerosis in Greece.Dynamics of production of MIP-1alpha, MCP-1 and MIP-2 and potential role of neutralization of these chemokines in the regulation of immune responses during experimental autoimmune neuritis in Lewis ratsProtective effect of Rolipram in experimental autoimmune neuritis: protection is associated with down-regulation of IFN-gamma and inflammatory chemokines as well as up-regulation of IL-4 in peripheral nervous systemIntranasal administration of recombinant mouse interleukin-12 increases inflammation and demyelination in chronic experimental autoimmune neuritis in Lewis ratsRolipram suppresses experimental autoimmune neuritis and prevents relapses in Lewis ratsP0 glycoprotein peptides 56-71 and 180-199 dose-dependently induce acute and chronic experimental autoimmune neuritis in Lewis rats associated with epitope spreadingEnhancement of acute phase and inhibition of chronic phase of experimental autoimmune neuritis in Lewis rats by intranasal administration of recombinant mouse interleukin 17: potential immunoregulatory roleHigh inflammation and mild demyelination in the peripheral nervous system induced by an intraneural injection of RR interleukin-4Nasal administration of recombinant rat IL-4 ameliorates ongoing experimental autoimmune neuritis and inhibits demyelinationHigh levels of IL-10 secreting cells are present in blood in cerebrovascular diseasesInflammation and severe demyelination in the peripheral nervous system induced by the intraneural injection of recombinant mouse interleukin-12Suppression of chronic experimental autoimmune neuritis by nasally administered recombinant rat interleukin-6Local effects of recombinant rat interleukin-6 on the peripheral nervous systemPatient compliance with SSRIs and gabapentin in painful diabetic neuropathyBurden of illness in painful diabetic peripheral neuropathyCognitive impairment in patients with neuropathic painMultiple-organ cavernous hemangiomas involving brain, skin, and lungIsolated headache as the sole manifestation of dural sinus thrombosisPeriventricular nodular heterotopia and epilepsyPsychological distress symptoms and illness perception in patients with epilepsy in Northwest GreeceReasons for Failed Trials of Disease-Modifying Treatments for Alzheimer Disease and Their Contribution in Recent ResearchDepression and quality of life in patients with epilepsy in Northwest GreeceRelating the blood-thinning effect of pentoxifylline to the reduction in the elastic modulus of human red blood cells: an in vivo study
P50
Q34989858-A9EBABF3-C1AA-4429-A3A5-BB4A0C5C2BC0Q38006774-8B747F51-E714-4FC2-ABBB-28A11626E7E2Q38262496-87712328-EC5A-4786-A551-ABD016D21899Q41565095-FF7BFA7B-2F15-43B6-BD57-FD08129553E6Q44225645-833BDF22-5521-4911-AC5F-DC28AD777343Q45933393-0B27BD6A-019D-45AD-A635-4946DD7D23A3Q47305266-931619B2-294F-4CB2-A0DF-97EDC995CDC7Q48135121-9E2BED02-F93F-42FD-A27E-3B96B8535FACQ48152863-940B3EFA-5577-4369-A6A4-246E1FF70015Q48963078-DBA35138-DF6A-4EFB-84B0-AC26308D0A7AQ50440481-457FC0B2-9A5E-4E3D-9CF2-B5DCBF443E38Q51026220-28956B59-011B-4741-8485-DD40D98651A8Q51109980-5E97DB5B-EDE3-4899-87AB-E396ED6FF280Q51426879-D1CAC472-01A9-4957-95DD-C2FE1BB8929EQ51462151-919A9951-62A7-4396-8430-220B694171F0Q51773492-4439FF35-46C9-4776-B6C5-C794D65C991DQ54360413-5C982336-044E-49F5-8B04-4A87AED76B4DQ63208629-C387A07C-D857-403D-ACD7-07E2F8E21536Q73189427-7CED4A8D-0ED2-4768-98C2-DC20EDE641C1Q73348699-4B843F95-085D-4CEA-8FFF-24B9965F435DQ73436931-4E105FAE-871D-42F4-933C-162445FED21CQ73589564-4277A288-CC4C-42FA-9C1C-93F1F814B836Q73721179-1906780D-954A-416F-9F83-60831E900F48Q73869533-D5B50696-A18D-49A2-8CAA-3B10F65E0498Q74520521-12BC760A-6793-4FBA-8A81-3C21E4A7E0F4Q77856405-39E86D5B-2DF3-442F-9A1E-DED58A81161DQ77995425-ABF069DE-C112-40B5-866C-A1C999FB1969Q78127320-B57C4124-D036-4A13-A8C6-E3F35EC5A4BAQ78157747-34CF5140-3BD9-4576-B0A8-9D5DC19A2C2FQ79809174-89F34B1C-3130-4D4B-8442-DE3CF832C6FCQ80270914-E9E1A762-1C00-49B3-8956-22043156D160Q80419532-D9CA2B17-6463-4FA3-BF06-8CB53A1C8B3EQ80621819-F1BA8A7F-455B-4FE4-9A10-238C90517BC2Q81406220-659592FA-8EB2-4804-9E85-EBBDDE544DF9Q82027318-1BEE28AD-308C-4E88-8278-04BA0A3162D6Q91566038-E5E606EE-18CB-4A25-9FF1-FB7386F6E89EQ91963043-D4C3738E-78F6-476C-9BDD-EB7DF50363FEQ92010062-B47E3386-15F5-417C-B77B-4FCDB1392E23Q93023638-FAF95015-8EAA-427E-BE50-4B85DDE23B06
P50
description
researcher
@en
wetenschapper
@nl
name
S H Pelidou
@en
S H Pelidou
@nl
type
label
S H Pelidou
@en
S H Pelidou
@nl
prefLabel
S H Pelidou
@en
S H Pelidou
@nl
P106
P31
P496
0000-0003-4524-1089